Long-term outcome of kidney function in patients with ANCA-associated vasculitis

被引:7
|
作者
Sachez-Alamo, Beatriz [1 ,2 ]
Moi, Laura [3 ]
Bajema, Ingeborg [4 ]
Berden, Annelies [5 ]
Flossmann, Oliver [6 ]
Hruskova, Zdenka [7 ]
Jayne, David [8 ]
Wester-Trejo, Maria [9 ]
Wallquist, Carin [10 ]
Westman, Kerstin [11 ]
机构
[1] Lund Univ, Dept Clin Sci Lund, Div Nephrol, Lund, Sweden
[2] Hosp Univ Sureste, Dept Nephrol, Madrid, Spain
[3] Univ Hosp Lausanne, Lausanne Univ, Dept Med, Div Immunol & Allergy, Lausanne, Switzerland
[4] Dept Pathol, Groningen, Netherlands
[5] Maasstad Hosp, Dept Rheumatol & Clin Immunol, Rotterdam, Netherlands
[6] Royal Berkshire Hosp, Dept Nephrol, Reading, England
[7] Charles Univ Prague, Gen Hosp Prague, Fac Med 1, Dept Nephrol, Prague, Czech Republic
[8] Univ Cambridge, Dept Med, Cambridge, England
[9] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands
[10] Skane Univ, Hosp Malmo, Dept Nephrol, Malmo, Sweden
[11] Lund Univ, Dept Clin Sci Lund, Div Nephrol, Lund, Sweden
关键词
ANCA-associated vasculitis; end-stage kidney disease; kidney histology scores; prognosis; transplantation; ANTIBODY-ASSOCIATED VASCULITIS; HISTOPATHOLOGICAL CLASSIFICATION; SPANISH REGISTRY; RENAL VASCULITIS; GLOMERULONEPHRITIS; BIOPSY; SURVIVAL; PROPOSAL; WEGENER; TRIALS;
D O I
10.1093/ndt/gfae018
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Kidney involvement is common in anti-neutrophil cytoplasm antibody-associated vasculitis (AAV) and the prognosis is determined by the severity of kidney damage. This study focused on long-term kidney outcomes, defining possible risk factors and comparing the performance of three different histological classifications to predict outcomes for patients with AAV. Methods. The dataset included 848 patients with newly diagnosed AAV who participated in seven randomized controlled trials (RCTs) (1995-2012). Follow-up information was obtained from questionnaires sent to the principal investigators of the original RCTs. Results. The cumulative incidence of end-stage kidney disease (ESKD) at 5 and 10 years was 17% and 22%, respectively. Patients who developed ESKD had reduced patient survival compared with those with preserved kidney function (hazard ratio 2.8, P < .001). Comparing patients with AAV and kidney involvement with a matched general population, patients with AAV had poor survival outcomes, even in early stages of chronic kidney disease. The main cause of death was infection followed by cardiovascular disease in patients developing ESKD and malignancy in those who did not. Some 34% of patients with initial need for dialysis recovered kidney function after treatment. Thirty-five out of 175 in need of kidney replacement therapy (KRT) during follow-up received a kidney transplant with good outcome; there was 86% patient survival at 10 years. In the subcohort of 214 patients with available kidney biopsies, three scoring systems were tested: the Berden classification, the Renal Risk Score and the Mayo Clinic Score. The scores highlighted the importance of normal glomeruli and severe glomerulosclerosis on kidney survival (P < .001 and P = .001, respectively). The Renal Risk Score demonstrated a moderate prediction of kidney survival (area under the curve 0.79; standard error 0.03, 95% confidence interval 0.71-0.83). Conclusions Early diagnosis of AAV is extremely important. Even milder forms of kidney involvement have an impact on the prognosis. Patients in need of KRT had the lowest survival rates, but kidney transplantation has shown favorable outcomes for eligible AAV patients. The three histologic scoring systems were all identified as independent prognostic factors for kidney outcome.
引用
收藏
页码:1483 / 1493
页数:11
相关论文
共 50 条
  • [1] Long-term outcome of kidney function in patients with ANCA-associated vasculitis (vol 39, pg 1483, 2024)
    Sanchez-Alamo, Beatriz
    Moi, Laura
    Bajema, Ingeborg
    Berden, Annelies
    Flossmann, Oliver
    Hruskova, Zdenka
    Jayne, David
    Wester-Trejo, Maria
    Wallquist, Carin
    Westman, Kerstin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024,
  • [2] Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood
    Calatroni, Marta
    Consonni, Filippo
    Allinovi, Marco
    Bettiol, Alessandra
    Jawa, Natasha
    Fiasella, Susanna
    Curi, Dritan
    Abu-Rumeileh, Sarah
    Tomei, Leonardo
    Fortunato, Laura
    Gelain, Elena
    Gianfreda, Davide
    Oliva, Elena
    Jeannin, Guido
    Salviani, Chiara
    Emmi, Giacomo
    Bodria, Monica
    Sinico, Renato
    Moroni, Gabriella
    Ramirez, Giuseppe A.
    Bozzolo, Enrica
    Tombetti, Enrico
    Monti, Sara
    Bracaglia, Claudia
    Marucci, Giulia
    Pastore, Serena
    Esposito, Pasquale
    Catanoso, Maria
    Crapella, Barbara
    Montini, Giovanni
    Roperto, Rosa
    Materassi, Marco
    Rossi, Giovanni
    Badalamenti, Salvatore
    Yeung, Rae
    Romagnani, Paola
    Ghiggeri, Gian Marco
    Noone, Damien
    Vaglio, Augusto
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (07): : 1043 - 1051
  • [3] Impact of different ANCA serotypes on the long-term outcome of ANCA-associated vasculitis patients
    Qi, Fumin
    Hao, Jian
    Wei, Wei
    ANNALS OF MEDICINE, 2023, 55 (02)
  • [4] THE LONG-TERM RENAL OUTCOME IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS: PREDICTIVE VALUE OF KIDNEY BIOPSY
    Biriukova, Ludmila
    Stolyarevich, Ekaterina
    Frolova, Nadia
    Artyukhina, Ludmila
    Tomilina, Natalia
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [5] Correction: Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood
    Calatroni, M.
    Consonni, F.
    Allinovi, M.
    Bettiol, A.
    Jawa, N.
    Fiasella, S.
    Curi, D.
    Abu Rumeileh, S.
    Tomei, L.
    Fortunato, L.
    Gelain, E.
    Gianfreda, D.
    Oliva, E.
    Jeannin, G.
    Salviani, C.
    Emmi, G.
    Bodria, M.
    Sinico, R. A.
    Moroni, G.
    Ramirez, G. A.
    Bozzolo, E.
    Tombetti, E.
    Monti, S.
    Bracaglia, C.
    Marucci, G.
    Pastore, S.
    Esposito, P.
    Catanoso, M. G.
    Crapella, B.
    Montini, G.
    Roperto, R.
    Materassi, M.
    Rossi, G. M.
    Badalamenti, S.
    Yeung, R. S. M.
    Romagnani, P.
    Ghiggeri, G. M.
    Noone, D.
    Vaglio, A.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (12): : 1877 - 1877
  • [6] LONG-TERM OUTCOME OF PATIENTS WITH ANCA-ASSOCIATED RENAL VASCULITIS TREATED WITH HEMODIALYSIS
    Iwatsubo, Shuji
    Inagaki, Hiroko
    Baba, Akiko
    Hisanaga, Shuichi
    Yamashita, Yasuhiro
    Sato, Yuji
    Fujimoto, Shouichi
    RHEUMATOLOGY, 2017, 56 : 156 - +
  • [7] Long-term rituximab for ANCA-associated vasculitis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2020, 2 (07): : E389 - E389
  • [8] Long-term survival of ANCA-associated vasculitis
    Flossmann, Oliver
    Berden, Annelies
    De Groot, Kirsten
    Harper, Lorraine
    Heijl, Caroline
    HOGlund, Peter
    Jayne, David
    Luqmani, Raashid
    Mahr, Alfred
    Mukhtyar, Chetan
    Pusey, Charles
    Rasmussen, Niels
    Westman, Kerstin
    APMIS, 2009, 117 : 139 - 139
  • [9] The long-term prognosis of patients with ANCA-associated vasculitis with renalinvolvement
    不详
    KIDNEY & BLOOD PRESSURE RESEARCH, 2005, 28 (02): : 88 - 88
  • [10] Long-Term Outcome in Patients with ANCA-Associated Vasculitis (AAV): The Monocentric Experience of Brescia
    Salviani, Chiara
    Gregorini, Gina A.
    Tedoldi, Gianluca
    Alberici, Federico
    Scolari, Francesco
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 503 - 503